| Withdrawn | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC NCT06592664 | Lisata Therapeutics, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent NCT07494994 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma NCT07126158 | Washington University School of Medicine | Phase 2 |
| Not Yet Recruiting | Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer NCT07436312 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Not Yet Recruiting | Axelopran in Advanced Cancers NCT07354919 | HealthPartners Institute | Phase 2 |
| Not Yet Recruiting | Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma NCT06705335 | Institut Bergonié | — |
| Recruiting | Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate NCT07230509 | Minia University | Phase 2 |
| Recruiting | Early Phase Study of KESONOTIDE™in Participants With Solid Tumours NCT06926075 | Filamon LTD | Phase 1 / Phase 2 |
| Recruiting | CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors NCT07179692 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) NCT07132541 | Minia University | Phase 1 |
| Not Yet Recruiting | A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Su NCT06913218 | Akeso | Phase 1 |
| Recruiting | Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer NCT07081360 | Minia University | Phase 3 |
| Recruiting | Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy NCT07022015 | Minia University | N/A |
| Recruiting | Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution NCT07034339 | First Affiliated Hospital of Zhejiang University | — |
| Recruiting | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease NCT06332274 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Recruiting | Reinforced Pancreaticojejunostomy With or Without glubran2 NCT06756074 | Minia University | Phase 2 |
| Recruiting | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539 | LaunXP Biomedical Co., Ltd. | Phase 1 |
| Recruiting | The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy NCT06282809 | HistoSonics, Inc. | N/A |
| Withdrawn | CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) NCT06110598 | Case Comprehensive Cancer Center | Phase 2 |
| Recruiting | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With NCT06263088 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer NCT06572813 | Zhejiang University | Phase 1 / Phase 2 |
| Recruiting | Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor NCT07433283 | Sichuan Enray Pharmaceutical Sciences Company | Phase 1 / Phase 2 |
| Recruiting | Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer NCT06479239 | University of Virginia | Phase 1 / Phase 2 |
| Recruiting | Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler NCT06764134 | University Hospital Heidelberg | — |
| Recruiting | Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Ph NCT06593431 | M.D. Anderson Cancer Center | Phase 3 |
| Enrolling By Invitation | The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) NCT06276764 | Adenocyte, LLC | — |
| Not Yet Recruiting | TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor NCT06619886 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | EARLY_Phase 1 |
| Recruiting | Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Anal NCT06549725 | Lipidica, a.s. | N/A |
| Recruiting | Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial NCT05744219 | Jon Unosson | Phase 3 |
| Recruiting | Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas NCT05851534 | Maastricht University Medical Center | N/A |
| Not Yet Recruiting | MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer NCT06549751 | Marker Therapeutics, Inc. | Phase 1 |
| Recruiting | Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017 | Nammi Therapeutics Inc | Phase 1 |
| Active Not Recruiting | Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors NCT06545942 | MOMA Therapeutics | Phase 1 |
| Not Yet Recruiting | Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumo NCT06531291 | RenJi Hospital | Phase 2 |
| Recruiting | Autologous CAR-T Cells Targeting B7-H3 in PDAC NCT06158139 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762 | Zhejiang Provincial People's Hospital | Phase 2 |
| Recruiting | GPC3/Mesothelin-CAR-γδT Cells Against Cancers NCT06196294 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 |
| Not Yet Recruiting | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors NCT04889742 | Charite University, Berlin, Germany | Phase 2 |
| Not Yet Recruiting | The Role of the Human Microbiome in Patients After Pancreatic Resection. NCT06381882 | St. Antonius Hospital | — |
| Recruiting | A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With So NCT06051695 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Enrolling By Invitation | Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery NCT06774170 | Dokuz Eylul University | N/A |
| Recruiting | A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470 | MacroGenics | Phase 1 |
| Not Yet Recruiting | Clinical Trial for Advanced or Metastatic Pancreatic Cancer NCT06255912 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(Cellg NCT06172634 | Soonchunhyang University Hospital | Phase 1 / Phase 2 |
| Recruiting | Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531 | Peking University Third Hospital | — |
| Recruiting | Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Canc NCT06228599 | Medical College of Wisconsin | N/A |
| Recruiting | PRIORITY-CONNECT 2 Pilot Trial NCT06212700 | Surgical Outcomes Research Centre (SOuRCe) | N/A |
| Recruiting | Promoting CT Engagement for Pancreatic Cancer With App NCT06252545 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Unknown | Gastric Venous Reconstruction After Total Pancreatectomy NCT04850430 | University Hospital Heidelberg | N/A |
| Recruiting | Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX NCT06349278 | Laval University | N/A |
| Recruiting | MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial NCT05975593 | Washington University School of Medicine | N/A |
| Unknown | Surgical Results of Resection of Locally Advanced Pancreatic Cancer NCT06206382 | Assiut University | — |
| Recruiting | Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer NCT06144762 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Terminated | Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors NCT06065059 | Tango Therapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vacci NCT05964361 | University Hospital, Antwerp | Phase 1 / Phase 2 |
| Recruiting | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients NCT05850130 | GERCOR - Multidisciplinary Oncology Cooperative Group | N/A |
| Recruiting | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malig NCT06126406 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Use of Ctdna in Patients With Gastrointestinal Tract Tumors NCT06202131 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604 | Sahlgrenska University Hospital | Phase 3 |
| Unknown | The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer NCT06208436 | Tianjin Medical University Cancer Institute and Hospital | — |
| Recruiting | Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations NCT06229340 | N.N. Petrov National Medical Research Center of Oncology | Phase 2 |
| Recruiting | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors NCT06010862 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Completed | Choices About Genetic Testing And Learning Your Risk With Smart Technology NCT06184867 | Rutgers, The State University of New Jersey | N/A |
| Recruiting | Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer NCT05679674 | Baptist Health South Florida | N/A |
| Recruiting | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid NCT06006390 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Recruiting | Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer NCT06065891 | Jon Unosson | N/A |
| Recruiting | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing NCT06036563 | Air Force Military Medical University, China | — |
| Withdrawn | Clinical Utility Study for Exo-PDAC NCT05702385 | Qure Healthcare, LLC | N/A |
| Recruiting | Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer NCT06050317 | Shandong Cancer Hospital and Institute | Phase 2 |
| Recruiting | A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid T NCT06043466 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Enrolling By Invitation | Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Ca NCT06076252 | Affiliated Hospital of Guangdong Medical University | N/A |
| Active Not Recruiting | Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) NCT05915351 | University of Kansas Medical Center | Phase 2 |
| Recruiting | Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Ca NCT05841420 | Morten Ladekarl | Phase 2 |
| Active Not Recruiting | A Supervised Prehabilitation Program for Patients With Pancreatic Cancer NCT05692323 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | Percutaneous Holmium Injection in Pancreatic Cancer NCT05880472 | Radboud University Medical Center | N/A |
| Unknown | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma NCT05997147 | Tianjin Medical University Cancer Institute and Hospital | — |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors NCT05736731 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Withdrawn | GI Organ Tracking Via Balloon Applicators NCT05471401 | Washington University School of Medicine | N/A |
| Active Not Recruiting | Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers NCT05220046 | University of Nebraska | Phase 1 |
| Active Not Recruiting | Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors NCT05704985 | DEKA Biosciences | Phase 1 |
| Active Not Recruiting | Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Ca NCT05669482 | Verastem, Inc. | Phase 1 / Phase 2 |
| Recruiting | Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers NCT05779917 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 |
| Withdrawn | Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver NCT05610826 | University of Chicago | Phase 1 / Phase 2 |
| Active Not Recruiting | Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial NCT05927298 | University Health Network, Toronto | — |
| Unknown | ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer NCT05493878 | Assiut University | — |
| Recruiting | Collection of Circulating Biomarkers in Pancreatic Cancer NCT05743049 | Abramson Cancer Center at Penn Medicine | — |
| Completed | Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline NCT05514171 | Hospital del Mar | — |
| Recruiting | ExoLuminate Study for Early Detection of Pancreatic Cancer NCT05625529 | Biological Dynamics | — |
| Completed | Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery NCT05111353 | Washington University School of Medicine | Phase 1 |
| Active Not Recruiting | Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemother NCT05638698 | University of Kansas Medical Center | Phase 2 |
| Unknown | Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine NCT06291779 | Ho-Seong Han | — |
| Completed | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor NCT06048367 | Sichuan Enray Pharmaceutical Sciences Company | Phase 1 |
| Recruiting | MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer NCT07045571 | Yingbin Liu, MD, PhD, FACS | — |
| Active Not Recruiting | A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancrea NCT05497778 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Patient-derived Organoids Drug Screen in Pancreatic Cancer NCT05351983 | Prof. Dr. med. Dres. h.c. Jan Schmidt, MME | N/A |
| Recruiting | Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker NCT05501379 | University Medicine Greifswald | — |
| Terminated | Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer NCT05435053 | Ismail Gögenur | Phase 2 |
| Recruiting | Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery NCT05245877 | Helsinki University Central Hospital | Phase 4 |
| Terminated | FOLFIRINOX + NIS793 in Pancreatic Cancer NCT05417386 | Colin D. Weekes, M.D., PhD | Phase 1 |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Recruiting | Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts NCT04473794 | Johns Hopkins University | — |
| Unknown | Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility NCT05511116 | Fondation Hôpital Saint-Joseph | — |
| Recruiting | Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes NCT05518643 | University of Thessaly | — |
| Active Not Recruiting | A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarci NCT05336266 | Andrew Hendifar, MD | EARLY_Phase 1 |
| Recruiting | ARGONAUT: Stool and Blood Sample Bank for Cancer Patients NCT04638751 | Persephone Biosciences | — |
| Recruiting | Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection NCT05517811 | University of Colorado, Denver | — |
| Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) NCT05403177 | University Health Network, Toronto | — |
| Withdrawn | Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas NCT05216120 | HonorHealth Research Institute | Phase 2 |
| Recruiting | ctDNA Assay in Patients With Resectable Pancreatic Cancer NCT05052671 | University of Oklahoma | — |
| Recruiting | Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) NCT05191940 | EBG MedAustron GmbH | N/A |
| Unknown | Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreati NCT05580887 | Moscow Clinical Scientific Center | — |
| Unknown | Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinic NCT05253313 | University of Aarhus | N/A |
| Terminated | Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy NCT05251233 | Washington University School of Medicine | Phase 2 |
| Recruiting | Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer NCT05356039 | Umeå University | — |
| Recruiting | Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC NCT04605913 | Mayo Clinic | Phase 1 / Phase 2 |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Active Not Recruiting | First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer NCT05156866 | TORL Biotherapeutics, LLC | Phase 1 |
| Unknown | Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma NCT04812808 | Hôpital Fribourgeois | N/A |
| Recruiting | Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma NCT05241249 | Susan E. Bates | Phase 2 |
| Active Not Recruiting | First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer NCT05159440 | TORL Biotherapeutics, LLC | Phase 1 |
| Withdrawn | Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors NCT05181865 | Flame Biosciences | Phase 1 / Phase 2 |
| Unknown | Less Than 100 Hours Hospital Stay After Pancreatico-duodenectomy, RCT NCT05192044 | National Cancer Institute, Egypt | N/A |
| Completed | Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer NCT05191498 | Radboud University Medical Center | N/A |
| Active Not Recruiting | Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer NCT04246203 | Ludwig-Maximilians - University of Munich | — |
| Recruiting | Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors NCT05187338 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 / Phase 2 |
| Terminated | Milademetan in Advanced/Metastatic Solid Tumors NCT05012397 | Rain Oncology Inc | Phase 2 |
| Recruiting | Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing NCT04981119 | A2 Biotherapeutics Inc. | — |
| Completed | Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer NCT05068752 | HonorHealth Research Institute | Phase 2 |
| Active Not Recruiting | CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab NCT05121038 | Anup Kasi | Phase 1 / Phase 2 |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarc NCT04862260 | CHU de Quebec-Universite Laval | EARLY_Phase 1 |
| Terminated | HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With S NCT05124743 | Alaunos Therapeutics | — |
| Recruiting | Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocar NCT04851106 | GCS Ramsay Santé pour l'Enseignement et la Recherche | — |
| Unknown | Peri-operative SLOG for Localized Pancreatic Cancer NCT05048524 | National Health Research Institutes, Taiwan | Phase 2 |
| Recruiting | Prognostic Factors in Periampullary Tumors and Cysts NCT05155878 | Umeå University | — |
| Active Not Recruiting | Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma NCT04331041 | Washington University School of Medicine | Phase 2 |
| Terminated | Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients NCT04536077 | Washington University School of Medicine | Phase 2 |
| Recruiting | Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer NCT05218889 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Recruiting | Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma NCT05248750 | Catholic University of the Sacred Heart | — |
| Active Not Recruiting | Stereotactic PAncreatic RadioTherapy Adjuvant Therapy NCT05043857 | Istituto Clinico Humanitas | N/A |
| Terminated | Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients NCT04843306 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Completed | Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo P NCT04263948 | Ramsay Générale de Santé | N/A |
| Unknown | NCI SBIR Contract for Patient Navigation Tool Prototype Development NCT04892927 | GMG Arcdata LLC | — |
| Active Not Recruiting | Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors NCT04902872 | Cybrexa Therapeutics | Phase 1 / Phase 2 |
| Unknown | Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. NCT04258072 | Samsung Medical Center | Phase 1 |
| Active Not Recruiting | An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Ga NCT04837833 | Memorial Sloan Kettering Cancer Center | N/A |
| Withdrawn | Pilot Study of 89-Zr Panitumumab in Pancreas Cancer NCT04833959 | Stanford University | Phase 1 |
| Completed | Role of Pre-operative CPET in Pancreatoduodenectomy NCT06068452 | East Lancashire Hospitals NHS Trust | — |
| Completed | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) NCT04825834 | Delfi Diagnostics Inc. | — |
| Active Not Recruiting | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma NCT04594772 | University of Cincinnati | Phase 2 |
| Completed | TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529 | The University of Hong Kong | Phase 2 |
| Completed | Relieving the Bile Ducts Prior to Pancreatoduodenectomy NCT05434520 | Rigshospitalet, Denmark | — |
| Unknown | Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organo NCT04777604 | Samsung Medical Center | — |
| Completed | Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition NCT04542291 | Washington University School of Medicine | Phase 1 |
| Unknown | Evaluation of the Impact of Pancreatectomy on Systemic Immunity NCT03978702 | Institut Paoli-Calmettes | N/A |
| Terminated | FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer NCT04141995 | University of Nebraska | Phase 2 |
| Completed | INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors NCT04436679 | University Hospital, Lille | — |
| Completed | Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy NCT04774198 | Rigshospitalet, Denmark | — |
| Unknown | An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Ge NCT04739046 | Seoul National University Bundang Hospital | Phase 2 |
| Withdrawn | Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care NCT04584775 | Medical University of Graz | N/A |
| Recruiting | SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells NCT04150042 | General Oncology, Inc. | Phase 1 |
| Withdrawn | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma NCT03760614 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Completed | Improvement of Care of Patients Undergoing Pancreaticoduodenectomy NCT04668781 | Helsinki University Central Hospital | N/A |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Active Not Recruiting | Pancreas Cancer Surveillance Using an Abbreviated MRI NCT04592393 | Seoul National University Hospital | N/A |
| Completed | Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery NCT04920019 | Mahidol University | N/A |
| Completed | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients Wi NCT04640480 | SN BioScience | Phase 1 |
| Unknown | Evaluating the Response to Neoadjuvant Chemotherapy With Circulating Tumor DNA in Pancreatic Cancer NCT04616131 | Central DuPage Hospital | — |
| Recruiting | Pancreatic Cancer Early Detection Consortium NCT04970056 | Arbor Research Collaborative for Health | — |
| Active Not Recruiting | Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NCT04140526 | OncoC4, Inc. | Phase 1 / Phase 2 |
| Completed | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. NCT05266300 | University of Southern Denmark | — |
| Unknown | The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients NCT04524260 | University of Zurich | N/A |
| Unknown | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy NCT04517019 | University Hospital Tuebingen | N/A |
| Recruiting | Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury NCT04485286 | Massachusetts General Hospital | Phase 2 |
| Active Not Recruiting | Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer ( NCT04281290 | University Medical Centre Ljubljana | N/A |
| Completed | Evolution of Body Connection After Surgery NCT04422730 | Institut Paoli-Calmettes | — |
| Unknown | Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs NCT04687410 | Peter Vilmann MD, DSc, HC, FASGE | N/A |
| Recruiting | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven NCT04429542 | Bicara Therapeutics | Phase 1 |
| Recruiting | Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy NCT04571294 | Humanitas Hospital, Italy | N/A |
| Completed | Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suff NCT04257448 | GWT-TUD GmbH | Phase 1 / Phase 2 |
| Completed | Advanced Endoscopy During COVID-19 NCT04385147 | Al-Azhar University | — |
| Completed | The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients NCT04528745 | University of Copenhagen | — |
| Completed | Trainee Involvement in ERCP Risk Score NCT04341909 | Clinical Hospital Colentina | — |
| Unknown | Validations of New cut-of for the Stratification of Postoperative Complications,Drains Management NCT04380506 | Campus Bio-Medico University | N/A |
| Completed | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies NCT04316078 | Sheba Medical Center | N/A |
| Completed | Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy NCT04191928 | Thomas Jefferson University | Phase 1 |
| Unknown | Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions NCT04324294 | Cedars-Sinai Medical Center | Phase 1 |
| Unknown | Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients NCT04269369 | Jessa Hospital | Phase 4 |
| Terminated | Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Ch NCT03956056 | Washington University School of Medicine | Phase 1 |
| Terminated | Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreati NCT04136769 | Ulrich Ronellenfitsch, MD | N/A |
| Unknown | The Microbiome of Pancreatic Cancer: "PANDEMIC" Study NCT04274972 | Azienda Ospedaliera Universitaria Integrata Verona | — |
| Completed | National Survey and Case-vignette Study of Clinical Decisions in Pancreatic Cancer NCT04755036 | Hospital Miguel Servet | — |
| Terminated | L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer NCT04203641 | Helix BioPharma Corporation | Phase 1 / Phase 2 |
| Recruiting | Stereotactic Magnetic Resonance Guided Radiation Therapy NCT04115254 | Dana-Farber Cancer Institute | N/A |
| Withdrawn | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer NCT04123574 | BioXcel Therapeutics Inc | EARLY_Phase 1 |
| Terminated | EUS-guided Laser Ablation in Pancreatic Adenocarcinoma NCT03784417 | Catholic University of the Sacred Heart | N/A |
| Unknown | Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncolog NCT04512209 | University Hospital, Ghent | N/A |
| Completed | A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer NCT04080024 | Spago Nanomedical AB | Phase 1 |
| Unknown | Effect of Preoperative Immunonutrition in Upper Digestive Tract NCT04027088 | Complexo Hospitalario Universitario de A Coruña | N/A |
| Withdrawn | Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B NCT03778879 | Alan Katz | Phase 1 / Phase 2 |
| Completed | ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer NCT04064034 | Mayo Clinic | N/A |
| Unknown | A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain NCT04014478 | Shanghai Golden Leaf MedTec Co. Ltd | N/A |
| Completed | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Pro NCT03883919 | Washington University School of Medicine | Phase 1 |
| Terminated | Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular I NCT04106167 | Fate Therapeutics | — |
| Withdrawn | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) NCT03697239 | Hitendra Patel | Phase 1 / Phase 2 |
| Unknown | Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management St NCT03951324 | Innovative Digestive Health Education and Research Inc | — |
| Withdrawn | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) NCT03908333 | Medical College of Wisconsin | Phase 1 / Phase 2 |
| Completed | Peptide-based Immunization for Colon- and and Pancreas-carcinoma NCT03871790 | CENTOGENE GmbH Rostock | — |
| Active Not Recruiting | Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer Wit NCT03716531 | Massachusetts General Hospital | N/A |
| Completed | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumo NCT03841110 | Fate Therapeutics | Phase 1 |
| Completed | Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX NCT03798769 | Massachusetts General Hospital | N/A |
| Unknown | Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Les NCT03210948 | Ospedali Riuniti di Foggia | N/A |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Completed | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. NCT03992664 | Cyprus University of Technology | N/A |
| Unknown | Evaluation of CEMIP in Pancreatic Cancer NCT03679910 | Assiut University | — |
| Unknown | Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids NCT03990675 | Technical University of Munich | N/A |
| Completed | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) NCT02905578 | Joseph J. Cullen | Phase 2 |
| Terminated | Study of ADCT-301 in Patients With Selected Advanced Solid Tumors NCT03621982 | ADC Therapeutics S.A. | Phase 1 |
| Recruiting | Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid NCT03755739 | Second Affiliated Hospital of Guangzhou Medical University | Phase 2 / Phase 3 |
| Recruiting | PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma NCT04099134 | University of Ulm | — |
| Enrolling By Invitation | Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy NCT04466189 | National Cancer Center, Korea | — |
| Withdrawn | CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites ( NCT03682744 | Sorrento Therapeutics, Inc. | Phase 1 |
| Completed | Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula NCT03410914 | Sunnybrook Health Sciences Centre | Phase 2 |
| Unknown | Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National NCT03400072 | Centre Hospitalier Universitaire de Besancon | N/A |
| Completed | Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles NCT03567863 | Société Française d'Endoscopie Digestive | N/A |
| Recruiting | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma NCT03484299 | University of Louisville | Phase 1 |
| Terminated | M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma NCT03451773 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer NCT03513198 | University of Medicine and Pharmacy Craiova | — |
| Completed | Bethanechol Prior to Pancreatic Surgery NCT03572283 | Columbia University | EARLY_Phase 1 |
| Completed | Patient Activation Through Counseling, Exercise and Mobilization NCT03411200 | Herlev and Gentofte Hospital | N/A |
| Recruiting | The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer NCT03637569 | Samsung Medical Center | — |
| Terminated | High-dose Vitamin D3 in Pancreas Cancer NCT03472833 | Medical University of Graz | Phase 3 |
| Unknown | PTFE Stents for Treatment of Malignant Biliary Strictures NCT03763214 | Johannes Vermehren | N/A |
| Unknown | Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples NCT04246710 | Catholic University of the Sacred Heart | — |
| Completed | A Study of ASN007 in Patients With Advanced Solid Tumors NCT03415126 | Asana BioSciences | Phase 1 |
| Completed | Early Recovery Outcomes After Standardized Fast-track Whipples Procedure NCT03566056 | Eske Kvanner Aasvang | — |
| Terminated | Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy NCT03122106 | Washington University School of Medicine | Phase 1 |
| Completed | Celiac Plexus Radio-Surgery for Pain Management NCT03323489 | Dr. Yaacov Lawrence | N/A |
| Completed | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model NCT03934606 | Abramson Cancer Center at Penn Medicine | — |
| Completed | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory NCT03199586 | Novita Pharmaceuticals, Inc. | Phase 1 |
| Unknown | Pancreatic Cancer & Surgical Resection NCT05170802 | Methodist Health System | — |
| Completed | Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery. NCT03466593 | Göteborg University | N/A |
| Completed | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) NCT03410030 | HonorHealth Research Institute | Phase 1 / Phase 2 |
| Completed | Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduoden NCT03269994 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Azacitidine and Pembrolizumab in Pancreatic Cancer NCT03264404 | Susan E. Bates | Phase 2 |
| Completed | Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source NCT03109041 | CivaTech Oncology | Phase 1 |
| Terminated | To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenviro NCT03277209 | Weill Medical College of Cornell University | Phase 1 |
| Completed | Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results NCT05226572 | University of Bologna | — |
| Unknown | RFA for Malignant Biliary Obstruction NCT03166436 | Institute for Clinical and Experimental Medicine | N/A |
| Completed | Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) NCT03532347 | Newcastle-upon-Tyne Hospitals NHS Trust | N/A |
| Recruiting | Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tu NCT03093688 | Shanghai Public Health Clinical Center | Phase 1 / Phase 2 |
| Completed | A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers NCT03172572 | S (Sjors) Klompmaker, MD | — |
| Terminated | Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Ab NCT02950025 | Washington University School of Medicine | Phase 2 |
| Completed | The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With NCT06553040 | Ege University | — |
| Completed | A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor NCT02999672 | Hoffmann-La Roche | Phase 2 |
| Unknown | Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersa NCT02944006 | Seoul National University Hospital | — |
| Unknown | Incidence of POPF in the Resection of the Left Pancreas With RFAT NCT03570502 | Hospital del Mar | — |
| Completed | Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemo NCT02853474 | Centre Oscar Lambret | Phase 3 |
| Completed | Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Nev NCT03174574 | Mayo Clinic | — |
| Active Not Recruiting | Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes NCT02917798 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Epidural Analgesia Use in Pancreatic Resections NCT02681796 | Washington University School of Medicine | Phase 1 |
| Terminated | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer NCT02608229 | Washington University School of Medicine | Phase 1 |
| Completed | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer NCT02632448 | Esperas Pharma Inc. | Phase 1 / Phase 2 |
| Withdrawn | The Role of Muscle Cachexia in Pancreatic Cancer NCT02515513 | University of Florida | N/A |
| Completed | Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. NCT04937322 | Methodist Health System | — |
| Completed | Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas NCT02973672 | Surgimab | Phase 1 / Phase 2 |
| Unknown | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) NCT03210298 | Sabine Rhode | — |
| Terminated | Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT02352831 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Completed | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients NCT02311361 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer ( NCT02707328 | The Cooper Health System | Phase 1 |
| Unknown | Intraoperative Radiation Therapy for Resectable Pancreas Cancer NCT02599662 | Loyola University | Phase 1 |
| Unknown | A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer NCT04024358 | Massimo Falconi | — |
| Completed | Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy NCT02307500 | Istituto Clinico Humanitas | Phase 2 |
| Completed | Radiofrequency Ablation for Biliopancreatic Malignancy NCT02468076 | Universitaire Ziekenhuizen KU Leuven | Phase 2 |
| Completed | Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement NCT04747600 | Zagazig University | — |
| Withdrawn | Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer NCT01784081 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Active Not Recruiting | Pancreatic Cancer Early Detection Program NCT02206360 | White Plains Hospital | — |
| Completed | International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs NCT02703545 | Johns Hopkins University | — |
| Recruiting | The Cancer of the Pancreas Screening-5 CAPS5)Study NCT02000089 | Johns Hopkins University | Phase 3 |
| Unknown | Pancreatic Cancer Recurrence in the Netherlands NCT04605237 | UMC Utrecht | — |
| Completed | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy NCT02021422 | Baylor Research Institute | Phase 1 |
| Completed | Tumor Registry Pancreatic Cancer NCT02089269 | iOMEDICO AG | — |
| Terminated | Maintenance Dovitinib for Colorectal and Pancreas Cancer NCT01888965 | Georgetown University | Phase 2 |
| Recruiting | Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer NCT01915225 | National Cancer Institute (NCI) | — |
| Completed | Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. NCT02078700 | Azienda USL Reggio Emilia - IRCCS | Phase 2 |
| Recruiting | Pancreas Registry and High Risk Registry NCT02775461 | Icahn School of Medicine at Mount Sinai | — |
| Unknown | A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer NCT02707315 | The Cooper Health System | EARLY_Phase 1 |
| Unknown | Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy NCT06135649 | Universita di Verona | — |
| Unknown | Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer NCT01771146 | Baylor Research Institute | N/A |
| Terminated | Gemcitabine and CT-011 for Resected Pancreatic Cancer NCT01313416 | Augusta University | Phase 2 |
| Recruiting | Quebec Pancreas Cancer Study NCT04104230 | George Zogopoulos | — |
| Withdrawn | The Role of Meat-borne Carcinogens in Pancreatic Cancer NCT01092689 | University of Minnesota | Phase 1 |
| Completed | Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control NCT02002806 | Indiana University | N/A |
| Completed | NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer NCT01521702 | Institut Paoli-Calmettes | Phase 3 |
| Completed | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic C NCT01446458 | Emory University | Phase 1 |
| Unknown | Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer NCT01411072 | AHS Cancer Control Alberta | N/A |
| Withdrawn | Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspi NCT01371240 | University Hospitals Cleveland Medical Center | EARLY_Phase 1 |
| Completed | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas NCT01231347 | NantCell, Inc. | Phase 3 |
| Completed | Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors NCT01286987 | Pfizer | Phase 1 |
| Completed | Registry Study - Whipple at the Splenic Artery NCT01155882 | Washington University School of Medicine | — |